Levenson Jessica C, Goldstein Tina R, Wallace Meredith L, Witt Rachel, Harvey Allison G, Buysse Daniel, Rofey Dana L, Suffoletto Brian, Miller Elizabeth
Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Department of Pediatrics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
J Clin Sleep Med. 2025 Mar 1;21(3):529-541. doi: 10.5664/jcsm.11456.
We examined the feasibility, acceptability, and impact of a sleep promotion program (SPP).
This pilot trial randomly assigned adolescents (13-15 years of age) with insufficient sleep duration and irregular sleep timing to SPP-continuation (n = 24; SPP in month 1, continuation treatment in month 2) or monitoring-SPP (n = 20; monitoring in month 1, SPP in month 2). SPP included 1 clinician session and at-home delivery of web-based reports of each youth's sleep diary data with accompanying intervention questions that prompt youth to engage in sleep behavior change. Attrition rate primarily measured feasibility. Program satisfaction measured acceptability. Total sleep time, sleep timing, and sleep timing regularity were measured via sleep diary at baseline, Follow-up 1, and Follow-up 2 (each ∼1 month apart). Linear mixed-effects models compared treatment arms on changes in sleep from baseline to Follow-up 1 (month 1). We also compared changes in sleep during month 1 to changes in sleep during month 2 among SPP-continuation participants.
Attrition rate was 8.5%, and 96.5% of participants rated the quality of care received as good or excellent. In month 1, SPP-continuation youth showed a significantly greater increase in mean total sleep time than monitoring-SPP youth (0.57 vs -0.38 hours; contrast = 0.95; confidence interval = 0.14, 1.76; = .024). SPP-continuation participants showed an increase in total sleep time during month 1 (0.51 hours) but a decrease during month 2 (-0.74 hours; contrast = -1.24; confidence interval = -2.06, -0.42; = .005). No other significant effects were observed.
SPP is highly feasible, acceptable, and associated with a significant increase in total sleep time early in treatment.
Registry: ClinicalTrials.gov; Name: Targeted Intervention for Insufficient Sleep among Typically-Developing Adolescents; URL: https://clinicaltrials.gov/ct2/show/NCT04163003; Identifier: NCT04163003.
Levenson JC, Goldstein TR, Wallace ML, et al. A sleep promotion program for insufficient sleep among adolescents: a pilot feasibility randomized controlled trial. 2025;21(3):529-541.
我们考察了一项睡眠促进计划(SPP)的可行性、可接受性及效果。
这项试点试验将睡眠时长不足且睡眠时间不规律的青少年(13 - 15岁)随机分为SPP延续组(n = 24;第1个月进行SPP,第2个月进行延续治疗)或监测 - SPP组(n = 20;第1个月进行监测,第2个月进行SPP)。SPP包括1次临床医生问诊,并通过网络向青少年提供其睡眠日记数据的报告,同时附带干预问题,促使青少年改变睡眠行为。流失率主要用于衡量可行性。项目满意度用于衡量可接受性。通过睡眠日记在基线、随访1和随访2(每次间隔约1个月)时测量总睡眠时间、睡眠时间及睡眠时间规律性。线性混合效应模型比较了治疗组从基线到随访1(第1个月)睡眠变化情况。我们还比较了SPP延续组参与者第1个月的睡眠变化与第2个月的睡眠变化。
流失率为8.5%,96.5%的参与者将所接受护理的质量评为良好或优秀。在第1个月,SPP延续组青少年的平均总睡眠时间增加幅度显著大于监测 - SPP组青少年(0.57小时对 - 0.38小时;对比 = 0.95;置信区间 = 0.14, 1.76;P = 0.024)。SPP延续组参与者在第1个月总睡眠时间增加(0.51小时),但在第2个月减少( - 0.74小时;对比 = - 1.24;置信区间 = - 2.06, - 0.42;P = 0.005)。未观察到其他显著效果。
SPP具有高度可行性、可接受性,且在治疗早期与总睡眠时间显著增加相关。
注册机构:ClinicalTrials.gov;名称:针对发育正常青少年睡眠不足的靶向干预;网址:https://clinicaltrials.gov/ct2/show/NCT04163003;标识符:NCT04163003。
Levenson JC, Goldstein TR, Wallace ML,等。一项针对青少年睡眠不足的睡眠促进计划:一项试点可行性随机对照试验。2025;21(3):529 - 541。